MEDIGUS (Israel) Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:3em;padding-top: 35px;;'>MDG</div>
MDGS -- Israel Stock  

ILA 31.30  0.30  0.97%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding MEDIGUS is 'Not Rated'. Macroaxis provides MEDIGUS buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding MEDIGUS positions. The advice algorithm takes into account all of MEDIGUS available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from MEDIGUS buy-and-hold prospective. Additionally see Stocks Correlation.

Time Horizon

Risk Tolerance

Execute Advice
Not Rated
For the selected time horizon MEDIGUS has a risk adjusted performance of (0.01274), jensen alpha of (0.19), total risk alpha of (0.85), sortino ratio of 0.0 and treynor ratio of (0.33)
Macroaxis buy or sell recommendations module can be used to complement MEDIGUS advice provided by average analyst sentiment. It analyzes the firm potential to grow using fundamental, technical, data market data available right now. To make sure MEDIGUS is not overpriced, please verify all MEDIGUS fundamentals including its Shares Outstanding, Price to Book, Revenue, as well as the relationship between Price to Earning and Price to Sales .

MEDIGUS Trading Alerts and Improvement Suggestions

MEDIGUS is not yet fully synchronised with the market data
MEDIGUS has high likelihood to experience some financial distress in the next 2 years
The company reported revenue of 459 K. Net Loss for the year was (6.17 M) with loss before overhead, payroll, taxes, and interest of (171 K).
MEDIGUS has accumulated about 8.79 M in cash with (3.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.

MEDIGUS current analysts recommendations

Target Median Price1.50
Target Mean Price1.50
Target High Price1.50
Number Of Analyst Opinions1
Target Low Price1.50

MEDIGUS Returns Distribution Density

Mean Return0.13Value At Risk4.41
Potential Upside4.87Standard Deviation2.90
 Return Density